Naveen Pemmaraju, Director of Leukemia-Cancer Network, Executive Director of Cancer Medicine, Director of BPDCN at the Department of Leukemia, and Professor at the Department of Leukemia at MD Anderson Cancer Center, shared a post on LinkedIn:
“Delighted to bring in the New Year by spending some time with my colleague Scott Kopetz, sparking inspiration as we discussed new ideas and new collaborations at the intersection of solid and liquid tumors dissecting common pathways (RAS, BRAF) and thinking of novel approaches to drug discovery in a new multi-disciplinary way.
Exhilarating new ideas — stay tuned in 2026, Happy New Year to all.”
More posts featuring Naveen Pemmaraju on OncoDaily.